Brand name · Small Molecule
Igalmi
Igalmi is a brand name for Dexmedetomidine sublingual film (BXCL501), developed by BioXcel Therapeutics, Inc..
- Status
- Phase 3 for Agitation in Alzheimer's disease
- Mechanism
- alpha-2A adrenoceptor Agonist
- Developer
- BioXcel Therapeutics, Inc.
Programs
- Dexmedetomidine sublingual film (BXCL501) for Agitation in Alzheimer's diseasePhase 3Active
- Dexmedetomidine sublingual film (BXCL501) for SchizophreniaFiled (NDA)Active
- Dexmedetomidine sublingual film (BXCL501) for Acute Stress DisorderPhase 2Recruiting
- Dexmedetomidine sublingual film (BXCL501) for Opioid use disorderPhase 1/2Active
Also known as
- BXCL501
- dexmedetomidine
- dexmedetomidine hydrochloride
- 113775-47-6
View the full Dexmedetomidine sublingual film (BXCL501) profile →